Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)

被引：0

作者：

Roeth, A. ^{[1
]}

Barcellini, W. ^{[2
]}

D'Sa, S. ^{[3
]}

Miyakawa, Y. ^{[4
]}

Broome, C. ^{[5
]}

Michel, M. ^{[6
]}

Kuter, D. ^{[7
]}

Jilma, B. ^{[8
]}

Tvedt, T. H. A. ^{[9
]}

Weitz, I. C. ^{[10
]}

Patel, P. ^{[11
]}

Jiang, X. ^{[11
]}

Reuter, C. ^{[11
]}

Su, J. ^{[11
]}

Shafer, F. ^{[11
]}

Lee, M. ^{[11
]}

Hobbs, W. ^{[11
]}

Berentsen, S. ^{[12
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England

[4] Saitama Med Univ Hosp, Thrombosis & Hemostasis Ctr, Saitama, Japan

[5] Georgetown Univ Hosp, Div Hematol, Washington, DC 20007 USA

[6] Henri Mondor Univ Hosp, AP HP, UPEC, Creteil, France

[7] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA

[8] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[9] Haukeland Hosp, Dept Med, Sect Hematol, Bergen, Norway

[10] Keck Sch Med USC, Los Angeles, CA USA

[11] Sanofi, Cambridge, England

[12] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ep90

引用

页码：169 / 170

页数：2

共 50 条

[1] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
Roth, Alexander
Barcellini, Wilma
D'Sa, Shirley
Miyakawa, Yoshitaka
Broome, Catherine M.
Michel, Marc
Kuter, David J.
Jilma, Bernd
Tvedt, Tor Henrik Anderson
Weitz, Ilene C.
Patel, Parija
Jiang, Xiaoyu
Reuter, Caroline
Su, Jun
Shafer, Frank
Lee, Michelle
Hobbs, William
Berentsen, Sigbjorn
BLOOD, 2020, 136
[2] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG -TERM FOLLOW-UP
Barcellinia, W.
Roeth, A.
D'Sa, S.
Miyakawa, Y.
Broome, C. M.
Michel, M.
Kuter, D. J.
Jilma, B.
Tvedt, T. H. Anderson
Weitz, I. C.
Patel, P.
Jiang, X.
Reuter, C.
Su, J.
Shafer, F.
Lee, M.
Hobbsb, W.
Berentsen, S.
HAEMATOLOGICA, 2021, 106 (10) : 107 - 107
[3] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
Roeth, A.
Barcellini, W.
D'Sa, S.
Miyakawa, Y.
Broome, C. M.
Michel, M.
Kuter, D. J.
Jilma, B.
Tvedt, T. H. Anderson
Lin, S.
Jiang, X.
Reuter, C.
Hobbs, W.
Berentsen, S.
HAEMATOLOGICA, 2020, 105 : S38 - S38
[4] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
Roth, Alexander
Barcellini, Wilma
D'Sa, Shirley
Miyakawa, Yoshitaka
Broome, Catherine M.
Michel, Marc
Kuter, David J.
Jilma, Bernd
Tvedt, Tor Henrik Anderson
Lin, Stella
Jiang, Xiaoyu
Reuter, Caroline
Hobbs, William
Berentsen, Sigbjorn
BLOOD, 2019, 134
[5] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
Roeth, A.
Barcellini, W.
Sa, D. S.
Miyakawa, Y.
Broome, C. M.
Michel, M.
Kuter, D. J.
Jilma, B.
Tvedt, Anderson T. H.
Lin, S.
Jiang, X.
Reuter, C.
Hobbs, W.
Berentsen, S.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
[6] Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
Roeth, Alexander
Barcellini, Wilma
D'Sa, Shirley
Miyakawa, Yoshitaka
Broome, Catherine M.
Michel, Marc
Kuter, David J.
Jilma, Bernd
Tvedt, Tor Henrik Anderson
Weitz, Ilene C.
Patel, Parija
Jiang, Xiaoyu
Reuter, Caroline
Su, Jun
Shafer, Frank
Lee, Michelle
Berentsen, Sigbjorn
HAEMATOLOGICA, 2022, 107 (07) : 1698 - 1702
[7] Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B
Roeth, Alexander
Berentsen, Sigbjorn
Barcellini, Wilma
D'Sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C.
Yamaguchi, Masaki
Nishimura, Jun-ichi
Vos, Josephine M. I.
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Jayawardene, Deepthi
Srivastava, Shruti
Wardecki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M.
ECLINICALMEDICINE, 2024, 74
[8] SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
Barcellini, W.
Roth, A.
Tvedt, T. H. Anderson
Miyakawa, Y.
Kuter, D. J.
Hobbs, W.
Su, J.
Jiang, X.
Morales Arias, J.
Weitz, I. C.
HAEMATOLOGICA, 2021, 106 (10) : 111 - 112
[9] Sutimlimab, a complement C1s inhibitor, improves quality of life in patients with cold agglutinin disease: Patient-reported outcomes results of the phase 3 cardinal study
Roeth, A.
Barcellini, W.
Tvedt, Anderson T. H.
Miyakawa, Y.
Kuter, D. J.
Hobbs, W.
Su, J.
Jiang, X.
Arias, Morales J.
Weitz, I. C.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 179 - 180
[10] Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease
Roeth, Alexander
Barcellini, Wilma
D'Sa, Shirley
Miyakawa, Yoshitaka
Broome, Catherine M.
Michel, Marc
Kuter, David J.
Jilma, Bernd
Tvedt, Tor Henrik Anderson
Weitz, Ilene C.
Yoo, Ronnie
Jayawardene, Deepthi
Vagge, Deepthi S.
Kralova, Katarina
Shafer, Frank
Wardecki, Marek
Lee, Michelle
Berentsen, Sigbjorn
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1246 - 1253

← 1 2 3 4 5 →